Novo Nordisk (NVO): The GLP-1 Pioneer Under Siege โ Can the Category Creator Defend Its Crown?
๐ค AI-SIMULATED BOARDROOM ยท NOT REAL STATEMENTS This is a fictional debate inspired by publicly known investment philosophies. All board member statements are AI simulations. THE BOARDROOM DEBATE โ JULY 2026 The Company at a Glance Novo Nordisk A/S (NVO) is the Danish pharmaceutical giant that, alongside Eli Lilly, ignited the global GLP-1 revolution. Its […]